Approval comes nine years after council published its strategic long-term vision for former Sutton Hospital site
Gensler’s plans for a £1bn cancer research hub in south London have been given the green light.
The 90,000sq m scheme for developers Aviva Capital Partners and Socius was approved by Sutton council yesterday, on World Cancer Day (4 February).
Phase one of the project will see the construction of a four-storey welcome pavilion and two blocks of five and seven storeys containing office space for life sciences occupiers, with the three buildings together containing more than 33,000sq m of floorspace.
These buildings are contained in the detailed component of the hybrid application, with the outline component, covering later phases, spanning three further development plots intended for two life sciences buildings and a residential block for key workers.
Buildings in the outline component have been allowed a maximum 45,000sq m of floorspace for life sciences, 800sq m for amenity and 10,200 sq m for residential accommodation, although the precise number of homes and size of the buildings will be decided later.
The application is the culmination of Sutton council’s long-term strategic plan to transform the 6.2ha site, which includes the former Sutton Hospital, into a world-leading life sciences and healthcare research and treatment district.
The council’s vision for the site was originally proposed in 2016 with Aviva Capital Partners and Socius appointed as private investment and development partners, partnering with the council, which is the site’s landowner.
The project team includes Aecom on costs, Arup on a range of consultant roles including structural engineer, MEP and fire, Montagu Evans on townscape, Savills on planning and Motionspot on accessibility. Gensler is lead architect, masterplanner, principal designer and landscape architect.
No comments yet